Wash., found procedures in the state that were previously approved in two weeks now take four to eight weeks to be authorized ...
The private equity-backed anesthesia provider bought and bullied its way to market dominance in Texas, driving up prices for ...
The insurer beat analyst expectations for adjusted earnings in the first quarter. But steeper Medicaid membership losses than ...
The pathway is designed to reduce the delay between FDA authorization and Medicare coverage for certain Class II and Class ...
Executives said consumer fears and aggressive denials from payers fueled declining volumes in the quarter, which led CHS to a $58 million loss. Still, the hospital operator said it expects volumes to ...
Though chatbots could have some benefits for mental health access, the physician lobby argued “immediate attention is ...
The data, compiled by the Brookings Center on Health Policy, shows that average prices for some services like imaging were seven-times higher than Medicare prices.
The Indianapolis-based insurer raised its 2026 earnings guidance after posting a better first quarter than Wall Street ...
The company argues the offering is a more comprehensive approach to weight management, allowing patients to receive ongoing ...
Premium hikes, plan redesigns and other efforts from the Minnesota-based company to wrangle medical spending bore fruit in the first quarter. UnitedHealth’s stock jumped accordingly.
Providers told regulators this week that switching to rebates in the 340B drug discount program would impose costs on clinics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results